Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2024-05-13 Legal Proceedings Report
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
주요사항보고서(소송등의제기)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the filing of a lawsuit (소송 등의 제기). Specifically, it details a request for an injunction against a new share issuance. Since the document pertains to legal proceedings and litigation involving the company, it falls under the 'Legal Proceedings Report' category.
2024-05-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Olipass Co., Ltd. It details the meeting date, location, agenda items (such as amendments to the articles of incorporation and appointment of directors), and provides management reference materials (경영참고사항) including business overviews and board activity reports. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes.
2024-05-03 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document), which is a standard regulatory filing in South Korea used by a company to solicit proxies from shareholders for an upcoming general meeting. It contains details about the meeting date, agenda items (such as changes to the articles of incorporation and election of directors), and instructions for electronic voting. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2024-05-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Olipass Co., Ltd., specifically detailing a correction (정정신고) to a previously filed Convertible Bond issuance. It outlines changes to maturity dates, conversion prices, and payment schedules. In the context of Korean regulatory filings (DART), this is a formal disclosure of capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2024-04-30 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal regulatory filing from a Korean company (Olipass) regarding the 'Resolution to Convene a General Meeting of Shareholders' (specifically an Extraordinary General Meeting). It details the agenda, including the appointment of directors and changes to business objectives. This type of document is a standard proxy solicitation/notice of meeting material provided to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2024-04-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds by a major shareholder (Son Hyung-seok) in Olipass Co., Ltd., resulting in a change in their shareholding status. This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks significant ownership changes and potential influence on management.
2024-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.